Swedbank
TXG icon

Swedbank’s 10x Genomics TXG Stock Holding History

Swedbank’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-17,988
Closed -$675K – 722
2024
Q1 		$675K Buy
17,988
+2,200
+14% +$96.7K 0.01% 532
2023
Q4 		$883K Sell
15,788
-400
-2% -$17.4K ﹤0.01% 642
2023
Q3 		$668K Buy
16,188
+1,700
+12% +$88.4K ﹤0.01% 641
2023
Q2 		$809K Buy
14,488
+88
+0.6% +$4.76K ﹤0.01% 638
2023
Q1 		$803K Buy
14,400
+275
+2% +$12.8K ﹤0.01% 644
2022
Q4 		$515K Hold
14,125
– – ﹤0.01% 668
2022
Q3 		$402K Sell
14,125
-1,054
-7% -$40.2K ﹤0.01% 698
2022
Q2 		$687K Buy
+15,179
New +$788K ﹤0.01% 672

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Swedbank's TXG Position: Q2 2024 in Review

Swedbank sold out of 10x Genomics (TXG) in Q2 2024, closing a stake of 17,988 shares — an estimated $675K sold.

Swedbank first reported a position in TXG in Q2 2022 and held it in 8 quarters. The position peaked at $883K in Q4 2023. 261 funds tracked by Wall St. Rank hold TXG as of Q2 2024.

  • Swedbank reported no remaining 10x Genomics position as of Q2 2024 after selling out during the quarter.
  • Swedbank sold 17,988 10x Genomics shares in Q2 2024, an estimated $675K.
  • Swedbank first reported a position in 10x Genomics in Q2 2022 and held it in 8 quarters.
  • Swedbank's 10x Genomics position peaked at $883K in Q4 2023.
  • 261 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2024.

Based on Swedbank's 13F filing for Q2 2024, filed 11 Jul 2024.